These observations imply that the induction of ferroptosis in malignant cells holds potential as a therapeutic strategy for inhibiting thyroid cancer progression through the targeted modulation of specific molecules or the inhibition of GPX4 expression and function. Here, GPX4 is linked to thyroid cancer.